New Progress of 211At Labelled Radiopharmaceuticals Recently
-
-
Abstract
211At, produced by cyclontron, is a promising radioisotope for tumor targeted radiotherapy due to its favorable radiobiological characteristics and cytotoxicity. The progress of radiopharmaceuticals labeled with 211At were reviewed with 50 references in recent years, including the preparation of 211At, the experimental and clinical research of labeled compounds, labeling methods, etc. Additionally, its situation, problems and prospect were discussed.
-
-